Maximus Inc. (MMS) Downgraded to Sell at Zacks Investment Research
According to Zacks, “MAXIMUS, Inc. is an extremely dynamic and complex organization that offers government and industry a range of unique services, products, and solutions. The diverse services and products that MAXIMUS offers may be categorized into three groups: Government Program Management and Operations, Consulting, and Systems. Government Program Management and Operations focuses on having a measurable impact on the lives of the citizens we help government serve. The insights of MAXIMUS Consulting, and the technological innovations advanced through Systems, help government gain program efficiencies and pursue improvements that in turn benefit citizens. “
A number of other brokerages also recently issued reports on MMS. Maxim Group upped their price target on Maximus from $71.00 to $74.00 and gave the company a buy rating in a report on Thursday, August 4th. KeyCorp initiated coverage on Maximus in a research note on Monday, July 11th. They issued a buy rating for the company. One investment analyst has rated the stock with a sell rating, two have issued a hold rating and seven have issued a buy rating to the stock. The stock currently has a consensus rating of Buy and a consensus target price of $63.00.
Maximus (NYSE:MMS) traded down 0.81% during trading on Wednesday, hitting $55.13. 62,059 shares of the company’s stock were exchanged. The company’s 50-day moving average price is $57.63 and its 200 day moving average price is $55.77. The firm has a market cap of $3.58 billion, a price-to-earnings ratio of 22.53 and a beta of 1.15. Maximus has a 12-month low of $45.15 and a 12-month high of $69.85.
Maximus (NYSE:MMS) last announced its quarterly earnings results on Thursday, August 4th. The company reported $0.75 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.71 by $0.04. The firm earned $617.10 million during the quarter, compared to the consensus estimate of $625.62 million. Maximus had a return on equity of 23.89% and a net margin of 6.91%. The firm’s quarterly revenue was up 7.8% compared to the same quarter last year. During the same period in the prior year, the company posted $0.62 earnings per share. Equities analysts forecast that Maximus will post $2.65 earnings per share for the current fiscal year.
In related news, Director Raymond B. Ruddy sold 18,000 shares of the company’s stock in a transaction on Thursday, July 14th. The stock was sold at an average price of $60.00, for a total transaction of $1,080,000.00. Following the transaction, the director now owns 295,552 shares of the company’s stock, valued at $17,733,120. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO Richard A. Montoni sold 25,000 shares of the company’s stock in a transaction on Thursday, August 25th. The stock was sold at an average price of $58.70, for a total value of $1,467,500.00. Following the transaction, the chief executive officer now directly owns 620,282 shares in the company, valued at approximately $36,410,553.40. The disclosure for this sale can be found here. Insiders own 3.60% of the company’s stock.
A number of hedge funds and other institutional investors have recently made changes to their positions in MMS. Massmutual Trust Co. FSB ADV raised its position in shares of Maximus by 3.6% in the first quarter. Massmutual Trust Co. FSB ADV now owns 3,879 shares of the company’s stock worth $204,000 after buying an additional 134 shares in the last quarter. Navellier & Associates Inc acquired a new position in shares of Maximus during the second quarter worth $208,000. Parametrica Management Ltd acquired a new position in shares of Maximus during the second quarter worth $216,000. LS Investment Advisors LLC raised its position in shares of Maximus by 70.9% in the second quarter. LS Investment Advisors LLC now owns 3,928 shares of the company’s stock worth $217,000 after buying an additional 1,630 shares in the last quarter. Finally, BW Gestao de Investimentos Ltda. raised its position in shares of Maximus by 28.6% in the second quarter. BW Gestao de Investimentos Ltda. now owns 4,994 shares of the company’s stock worth $277,000 after buying an additional 1,110 shares in the last quarter. 99.00% of the stock is currently owned by hedge funds and other institutional investors.
Maximus Company Profile
MAXIMUS, Inc provides business process services (BPS) to Government health and human services agencies. The Company is primarily focused on operating Government-sponsored programs, such as Medicaid, children’s health insurance program (CHIP), health insurance exchanges and other health care reform initiatives, Medicare, welfare-to-work, child support services and other Government programs.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Maximus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus Inc. and related companies with MarketBeat.com's FREE daily email newsletter.